1. Home
  2. CRBU

CRBU

Caribou Biosciences Inc.

Logo Caribou Biosciences Inc.

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

as 04-19-2024 3:32pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.

Founded: 2011 Country:
United States
United States
Employees: N/A City: BERKELEY
Market Cap: 392.9M IPO Year: 2021
Target Price: $22.00 AVG Volume (30 days): 1.6M
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.38 EPS Growth: N/A
52 Week Low/High: $3.44 - $8.59 Next Earning Date: 05-07-2024
Revenue: $34,477,000 Revenue Growth: 148.91%
Revenue Growth (this year): -63.69% Revenue Growth (next year): 5.68%

Share on Social Networks: